Gilead Faces Stronger Hepatitis C Rival on Merck & Co.’s Deal
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) MRK US (Merck & Co Inc) IDIX US (Idenix Pharmaceuticals Inc) ABBV US (AbbVie Inc) ACHN US (Achillion Pharmaceuticals Inc)
People Alethia Young (Deutsche Bank Securities Inc) Andrea Bettinelli (Royal Bank Of Scotland NV) Brian Skorney (Robert W Baird & Co Inc) Cara Miller (Gilead Sciences Inc) Michael J Yee (RBC Capital Markets) Pamela Eisele (Merck & Co Inc)
Topics Viral Hepatitis Cancers
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283